Icon

Tybost - (150 mg; Tablet, Oral)

Cobicistat Gilead
150 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
None
Indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection
Yes
***** *** *** ***** ** **** **** ** **** ****** '*** (**** *, ****) *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ***** ***** *** ***** ** ********* *** *** *****. ** ****** ***** ** ****** ***** *** ****** ** ****** '*** ** ** ** *** ******** ******.
Tybost Patent 1 Patent 2
***** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** **** **, **** ******* ******** ***** **** ****
  1. *** **, **** : ***** ******** ****** ***** *** **** ** **** ****** '*** (**** *, ****).
  2. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** *** *** ******** ******** ** **** ********.
  3. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** ** ******** *** *** **** ******.
  4. *** **, **** : ********** ********* **** ***** *** ****** '*** (**** *, ****) *.*. *** **** ****** ** ****.
  5. *** **, **** : ***** ******** ****** ***** *** **** ** **** ****** ******* ** (****** ** *** **, *****- *** **
  6. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** *** *** ******** ******** ** **** ********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.